SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Jonsson R, Brokstad K. Sjögren's syndrome. In: AustenKF, FrankMM, AtkinsonJP, CantorH, editors. Samter's immunologic diseases. 6th ed. Philadelphia: Lippincott, Williams & Wilkins; 2001. p. 495504.
  • 2
    Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjogren's syndrome: proposed criteria for classification. Arthritis Rheum 1986; 29: 57785.
  • 3
    Manoussakis MN, Moutsopoulos HM. Sjögren's syndrome: autoimmune epithelitis. Baillieres Best Pract Res Clin Rheumatol 2000; 14: 7395.
  • 4
    Brun JG, Jacobsen H, Kloster R, Cuida M, Johannesen AC, Hoyeraal HM, et al. Use of a sicca symptoms questionnaire for the identification of patients with Sjögren's syndrome in a heterogeneous hospital population with various rheumatic diseases. Clin Exp Rheumatol 1994; 12: 64952.
  • 5
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 6
    Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993; 36: 3407.
  • 7
    Brun JG, Jonsson R, Haga HJ. Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. J Rheumatol 1994; 21: 7338.
  • 8
    Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 65962.
  • 9
    Ulvestad E, Kanestrom A, Madland TM, Thomassen E, Haga HJ. Clinical utility of diagnostic tests for rheumatoid factor. Scand J Rheumatol 2001; 30: 8791.
  • 10
    Ulvestad E, Kanestrom A, Madland TM, Thomassen E, Haga HJ, Vollset SE. Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice. Scand J Immunol 2000; 52: 30915.
  • 11
    Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 1974; 18: 48191.
  • 12
    Workshop on diagnostic criteria for Sjögren's syndrome. Clin Exp Rheumatol 1989; 7: 2139.
  • 13
    Averns H, Hall J, Webley M. Role of opticare eye drop delivery system in patients with rheumatoid arthritis. J Rheumatol 1999; 26: 26158.
  • 14
    Andonopoulos AP, Drosos AA, Skopouli FN, Moutsopoulos HM. Sjögren's syndrome in rheumatoid arthritis and progressive systemic sclerosis: a comparative study. Clin Exp Rheumatol 1989; 7: 2079.
  • 15
    Jensen JL, Uhlig T, Kvien TK, Axell T. Characteristics of rheumatoid arthritis patients with self-reported sicca symptoms: evaluation of medical, salivary and oral parameters. Oral Dis 1997; 3: 25461.
  • 16
    Mody GM, Hill JC, Meyers OL. Keratoconjunctivitis sicca in rheumatoid arthritis. Clin Rheumatol 1988; 7: 23741.
  • 17
    Uhlig T, Kvien TK, Jensen JL, Axell T. Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis. Ann Rheum Dis 1999; 58: 41522.
  • 18
    Thomas E, Hay EM, Hajeer A, Silman AJ. Sjögren's syndrome: a community-based study of prevalence and impact. Br J Rheumatol 1998; 37: 106976.
  • 19
    Dafni UG, Tzioufas AG, Staikos P, Skopouli FN, Moutsopoulos HM. Prevalence of Sjögren's syndrome in a closed rural community. Ann Rheum Dis 1997; 56: 5215.
  • 20
    Schein OD, Hochberg MC, Munoz B, Tielsch JM, Bandeen-Roche K, Provost T, et al. Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med 1999; 159: 135963.
  • 21
    Hay EM, Thomas E, Pal B, Hajeer A, Chambers H, Silman AJ. Weak association between subjective symptoms of and objective testing for dry eyes and dry mouth: results from a population based study. Ann Rheum Dis 1998; 57: 204.
  • 22
    Jacobsson LT, Axell TE, Hansen BU, Henricsson VJ, Larsson A, Lieberkind K, et al. Dry eyes or mouth—an epidemiological study in Swedish adults, with special reference to primary Sjögren's syndrome. J Autoimmun 1989; 2: 5217.
  • 23
    Tomsic M, Logar D, Grmek M, Perkovic T, Kveder T. Prevalence of Sjögren's syndrome in Slovenia. Rheumatology 1999; 38: 16470.
  • 24
    Hamideh F, Prete PE. Ophthalmologic manifestations of rheumatic diseases. Semin Arthritis Rheum 2001; 30: 21741.
  • 25
    Martinez Castro E, Olive Marques A, Bonet Llorach M, Carbonell Abello J, Cobo Valeri E, Junca Valdor S. [Rheumatoid arthritis and Sjögren's syndrome: special reference to the course time of rheumatoid arthritis]. Med Clin (Barc) 1990; 94: 6559.
  • 26
    Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993; 36: 72940.